Perrigo | PRGO - Операционный доход





Операционный доход Изменить Дата
AbbVie USD 5.81B 1.23B 2025-12
Abbott USD 2.25B 73M 2025-12
Bayer EUR 1.11B 1.65B 2025-12
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Coherus Biosciences USD -45.43M 3.13M 2025-03
Corcept Therapeutics USD 4.49M 5.73M 2025-12
Dr.Reddys Laboratories INR 13.94B 2.31B 2025-12
Eli Lilly USD 8.99B 599.9M 2025-12
J&J USD 5.59B 1.81B 2025-12
Merck USD 6.24B 318M 2025-12
Nestle CHF 7.14B 689M 2025-06
Pacira USD 3.19M 9.96M 2025-12
Perrigo USD 84.4M 9M 2025-12
Pfizer USD 4.65B 3.99B 2025-12
Phibro Animal Health USD 25.53M 7.83M 2024-12
Prestige Brands USD 82.49M 2.82M 2025-12
Reckitt Benckiser GBP 747M 92M 2024-12
Sanofi EUR 1.7B 2.17B 2025-12
Supernus Pharmaceuticals USD 13.82M 74.01M 2025-12
Teva Pharmaceutical Industries USD 487M 581M 2025-12
Xeris Pharmaceuticals USD 6.73M 2.25M 2025-09
Zoetis USD 835M 101M 2025-12